WHO releases its first-ever Guidance to tackle Antibiotic pollution from manufacturing processes | Current Affairs | Vision IAS
News Today Logo

    WHO releases its first-ever Guidance to tackle Antibiotic pollution from manufacturing processes

    Posted 12 Sep 2024

    2 min read

    It addresses the antibiotic discharge from manufacturing which is recognised as a significant driver of the growing Antimicrobial Resistance (AMR) crisis.

    AMR caused by pharmaceutical manufacturing

    • Wastewater generated from antibiotic manufacturing, containing antibiotic residue, pollutes the water bodies like rivers and also seeps into the land.
    • Currently, antibiotic pollution from manufacturing is largely unregulated and quality assurance criteria typically do not address environmental emissions.

    About AMR

    • AMR occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines. (As per WHO)
    • It is a natural process that happens over time through genetic changes in pathogens. 
    • Its emergence and spread is accelerated by human activity, mainly the misuse and overuse of antimicrobials.
    • The creation of “superbugs” affects healthcare everywhere, but has especially poor outcomes in patients suffering from multiple diseases.

    Concerns related to AMR

    • Human and animal health: WHO lists AMR among the top 10 threats for global health. 
      • In 2019, 1.27 million deaths were directly attributed to drug-resistant infections globally.
    • Environment: AMR has a potential to negatively impact biodiversity through pollution and rise of zoonotic diseases.
    • Food and nutrition security: AMR threatens agriculture and animal husbandry. 
    • Economic development and social equity: productivity losses, increased healthcare costs and rise in poverty.

    Initiatives to tackle AMR

    • Adopting One Health Approach: Integrated approach aiming at sustainably balancing and optimising health of people, animals and ecosystems.
    • WHO Good Manufacturing Practices (GMP), 2020: Inclusion of environmental aspects of manufacturing linked to waste management etc.
    • National action plan on containment of Antimicrobial Resistance (NAP-AMR), 2017
    • Ban on 40 fixed dose combinations (FDCs) which were found inappropriate.
    • Ban on Colistin as growth promoter in poultry.
    • Development of antimicrobial vaccine, AV0328: Bharat Biotech in collaboration with a US firm.
    • Tags :
    • AMR
    • Pharmaceutical Sector
    • Antimicrobial Resistance
    Watch News Today
    Subscribe for Premium Features